| 前收市價 | 1,641.50 |
| 開市 | 1,643.00 |
| 買盤 | 1,642.50 x 0 |
| 賣出價 | 1,642.00 x 0 |
| 今日波幅 | 1,626.00 - 1,656.00 |
| 52 週波幅 | 1,261.00 - 1,656.00 |
| 成交量 | |
| 平均成交量 | 330,070 |
| 市值 | 2.552T |
| Beta 值 (5 年，每月) | 0.19 |
| 市盈率 (最近 12 個月) | 37.32 |
| 每股盈利 (最近 12 個月) | 44.11 |
| 業績公佈日 | 無 |
| 遠期股息及收益率 | 30.74 (1.87%) |
| 除息日 | 2024年2月22日 |
| 1 年預測目標價 | 1,146.16 |
ZacksPharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Merck (MRK), Sanofi (SNY), Novartis (NVS) and AstraZeneca (AZN) announce their first-quarter results.
ZacksFusion (FUSN) to Report Q1 Earnings: Here's What to Expect
Fusion (FUSN) is expected to provide updates regarding the developmental program of its lead candidate, FPI-2265, for prostate cancer in the first-quarter earnings release.
Investor's Business DailyAstraZeneca Flirts With A Breakout After Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge
AstraZeneca stock bolted higher Thursday — and is now within striking distance of a breakout — after its cancer drugs propelled a sales beat.
